RXRX · Recursion Pharmaceuticals, Inc. · Executive Compensation

$3.34 -0.10 (-2.88%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.94B

535.34M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	former Chief Executive Officer and President and current Chair of the Board	$680,000	—	$3,808,302	$4,846,699	$256,777	$15,731	$9,607,508
Najat Khan	current Chief Executive Officer and President	$600,000	—	$1,944,547	$2,501,058	$256,777	$46,683	$5,349,065
Ben Taylor	Chief Financial Officer	$538,680	—	$253,881	$323,110	$205,226	$7,586	$1,328,483

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Najat Khan	Chief R&D and Chief Commercial Officer	$285,000	$500,000	$3,647,774	$4,592,021	$115,824	$54,185	$9,194,805
Christopher C. Gibson	Chief Executive Officer	$600,000	—	$3,364,500	$4,274,816	$241,865	$18,405	$8,499,587
Ben Taylor	Chief Financial Officer	$53,392	—	$2,255,389	$5,662,543	$200,327	—	$8,171,651
Tina Marriott	Former Chief Operating Officer and President	$530,000	—	$2,259,736	$2,871,148	$213,648	$19,072	$5,893,604
Michael Secora	Former Chief Financial Officer	$475,000	—	$1,757,577	$2,233,116	—	$577,813	$5,043,506
David Mauro	Chief Medical Officer	$525,000	—	$502,159	$638,032	$211,626	$56,773	$1,933,590

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	Chief Executive Officer	$560,833	—	$3,478,140	$4,328,352	$224,483	$21,400	$8,613,209
Tina Marriott	Former Chief Operating Officer and President	$485,733	—	$1,855,872	$2,309,529	$194,419	$22,092	$4,867,645
Michael Secora	Former Chief Financial Officer	$435,583	—	$1,730,759	$2,153,839	$174,369	$19,830	$4,514,381
David Mauro	Chief Medical Officer	$303,333	—	$1,672,553	$2,181,756	$121,634	$33,190	$4,312,466
Shafique Virani	Former Chief Corporate Development Officer	$520,417	—	$908,463	$1,130,537	$208,442	$36,182	$2,804,040

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	Chief Executive Officer	$497,500	—	$2,573,043	$3,047,682	$185,478	$12,200	$6,315,903
Tina Marriott	Former Chief Operating Officer and President	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,762,240
Tina Marriott Larson	Chief Operating Officer and President	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,750,640
Michael Secora	Former Chief Financial Officer	$348,250	—	$721,107	$845,127	$129,834	$46,104	$2,090,422
Shafique Virani	Former Chief Corporate Development Officer	$488,333	—	$497,181	$588,894	$181,906	$11,600	$1,767,914
Ramona Doyle	Chief Medical Officer	$167,933	—	$475,848	$563,625	—	$359,058	$1,207,406

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shafique Virani	Former Chief Corporate Development Officer	$500,000	—	—	—	$175,000	$13,174	$688,174
Christopher C. Gibson	Chief Executive Officer	$485,417	—	—	—	$175,000	$13,174	$673,591
Ramona Doyle	Chief Medical Officer	$440,282	—	—	—	$154,000	$13,174	$607,456
Tina Marriott Larson	Chief Operating Officer and President	$428,771	—	—	—	$154,000	$13,174	$595,945
Tina Marriott	Chief Operating Officer and President	$428,771	—	—	—	$154,000	$13,174	$595,945
Michael Secora	Chief Financial Officer	$307,708	$63,460	—	—	$126,000	$13,174	$510,342

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Secora	Chief Financial Officer	$170,833	$63,000	—	$3,431,798	$15,357	$37,500	$3,718,488
Christopher C. Gibson	Chief Executive Officer	$269,643	$13,000	—	$2,268,661	$20,444	$12,700	$2,584,448
Shafique Virani	Chief Corporate Development Office	$413,541	$13,000	—	$991,749	$28,158	$20,523	$1,466,974
Ramona Doyle	Chief Medical Officer	$3,666	—	—	$1,134,331	—	—	$1,137,997
Tina Marriott Larson	Chief Operating Officer and President	$408,192	$13,000	—	$226,866	$30,070	$12,700	$690,828

Executive changes

Person	Role	Change	Effective	Filed
Vicki Goodman, M.D.	Chief Medical Officer	Appointed	2026-04-06	2026-03-25
Robert Hershberg, M.D., Ph.D.	Vice Chair and Lead Independent Director	Appointed	2026-01-01	2025-11-05
Christopher Gibson, Ph.D.	Chair of the Board	Appointed	2026-01-01	2025-11-05
Najat Khan, Ph.D.	Chief Executive Officer and President	Appointed	2026-01-01	2025-11-05
Namandjé Bumpus	Class III Director	Appointed	2025-03-15	2025-03-18
Elaine Sun	Class III Director	Appointed	2025-03-15	2025-03-18

Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 194 filings 194 filers Visit website Investor relations